Barclays raises target for Great-West Lifeco stock from CAD 87.00 to CAD 91.00
Published on 10/16/2026 at 10:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and earnings
- Barclays raised its Great-West Lifeco target from CAD 87.00 to CAD 91.00 on October 7, 2026.
- Adjusted earnings per share reached CAD 1.42 against CAD 1.37 expected in the second quarter of 2026.
- Great-West Lifeco stock trades at EUR 57.69 at 10:37 a.m. CEST at Lang & Schwarz on October 16, 2026.
Great-West Lifeco (CA39138C1068) is trading at EUR 57.69 at Lang & Schwarz on October 16, 2026, at 10:37 a.m. CEST. Barclays raised its price target for the insurer from CAD 87.00 to CAD 91.00 on October 7, 2026, while maintaining an Equal Weight rating, according to Benzinga.
Target rises as rating stays cautious
The Barclays move gives investors a fresh valuation marker without changing the firm's cautious stance. The new CAD 91.00 target is CAD 4.00 above the previous level, and the unchanged Equal Weight rating keeps the emphasis on valuation rather than a stronger recommendation.
Great-West Lifeco operates through Canada Life, Empower and Irish Life across Canada, the United States and Europe. The company describes its activities as insurance, retirement savings, wealth and asset management, and reinsurance, according to Great-West Lifeco.
What did the second quarter deliver?
In the second quarter of 2026, adjusted earnings per share reached CAD 1.42 against a CAD 1.37 consensus estimate. The same period also included a planned CAD 340.00 million acquisition of Milliman's retirement business, while Empower exceeded USD 2.00 trillion in workplace client assets, as reported by Investing.com.
Three dated steps for investors
On July 29, 2026, Great-West Lifeco reported adjusted earnings per share of CAD 1.42 against CAD 1.37 expected. On July 29, 2026, the company also announced the CAD 340.00 million Milliman retirement-business acquisition. On October 7, 2026, Barclays raised its target from CAD 87.00 to CAD 91.00 while retaining Equal Weight.
Next reporting date
Great-West Lifeco is scheduled to release its next earnings report on November 4, 2026, according to Investing.com.
Stock price and valuation context
The company reported 33,430 employees and more than CAD 4.6 billion in base earnings as of December 31, 2025. A separate market overview showed a market capitalization of CAD 80.7 billion and a 52-week range of CAD 57.56 to CAD 95.96 as of October 15, 2026, while listing Great-West Lifeco on the Toronto Stock Exchange under ticker GWO.
Great-West Lifeco stock was trading at EUR 57.69 at Lang & Schwarz on October 16, 2026, at 10:37 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Great-West Lifeco stock.
Great-West Lifeco stock facts
- Company: Great-West Lifeco Inc.
- ISIN: CA39138C1068
- Ticker: GWO
- Primary exchange: Toronto Stock Exchange
- Price Lang & Schwarz (as of October 16, 2026, 10:37 a.m. CEST): EUR 57.69
- Market capitalization: CAD 80.7 billion (as of October 15, 2026)
- 52-week range: CAD 57.56-CAD 95.96 (as of October 15, 2026)
- Sector / Industry: Financials / Life Insurance
- Next earnings date: November 4, 2026
Market context: Market report S&P/TSX Composite.
